Multidrug-resistant tuberculosis in children: evidence from global surveillance

被引:68
作者
Zignol, Matteo [1 ]
Sismanidis, Charalambos [1 ]
Falzon, Dennis [1 ]
Glaziou, Philippe [1 ]
Dara, Masoud [2 ]
Floyd, Katherine [1 ]
机构
[1] WHO, STOP TB Dept, CH-1211 Geneva 27, Switzerland
[2] WHO, Reg Off Europe, TB & MXDR TB Programme, DK-2100 Copenhagen, Denmark
关键词
ANTITUBERCULOSIS DRUG-RESISTANCE; WESTERN CAPE PROVINCE; PULMONARY TUBERCULOSIS; CHILDHOOD TUBERCULOSIS; SOUTH-AFRICA; CONTACT; MANAGEMENT;
D O I
10.1183/09031936.00175812
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Multidrug-resistant tuberculosis (MDR-TB) can affect persons of any age, but it remains unknown whether children are more or less likely than adults to have MDR-TB. Representative drug resistance surveillance data reported to the World Health Organization between 1994 and 2011 were analysed to test the association between MDR-TB and age group (children aged <15 years versus adults aged >= 15 years), using odds ratios derived by logistic regression with robust standard errors. Of 85 countries with data from nationwide surveys or surveillance systems, 35 reported at least one paediatric MDR-TB case. Aggregated data on age and drug susceptibility testing for 323 046 tuberculosis cases notified in these 35 countries were analysed. Odds ratios for MDR-TB in children compared to adults varied widely between countries. In Germany, Namibia, South Africa, the UK and the USA, MDR-TB was positively associated with age <15 years. In the remaining countries no association was established. Despite the limitations intrinsic to the use of surveillance data and to the challenges of diagnosing childhood tuberculosis, our analysis suggests that proportions of MDR-TB in children and adults are similar in many settings. Of particular concern is the association found between age <15 years and MDR-TB in southern African countries with high HIV prevalence.
引用
收藏
页码:701 / 707
页数:7
相关论文
共 30 条
[1]  
[Anonymous], 2011, TUB UK
[2]  
[Anonymous], WHO PUBL
[3]   Tuberculosis burden in households of patients with multidrug-resistant and extensively drug-resistant tuberculosis: a retrospective cohort study [J].
Becerra, Mercedes C. ;
Appleton, Sasha C. ;
Franke, Molly F. ;
Chalco, Katiuska ;
Arteaga, Fernando ;
Bayona, Jaime ;
Murray, Megan ;
Atwood, Sidney S. ;
Mitnick, Carole D. .
LANCET, 2011, 377 (9760) :147-152
[4]   Rapid Molecular Detection of Tuberculosis and Rifampin Resistance [J].
Boehme, Catharina C. ;
Nabeta, Pamela ;
Hillemann, Doris ;
Nicol, Mark P. ;
Shenai, Shubhada ;
Krapp, Fiorella ;
Allen, Jenny ;
Tahirli, Rasim ;
Blakemore, Robert ;
Rustomjee, Roxana ;
Milovic, Ana ;
Jones, Martin ;
O'Brien, Sean M. ;
Persing, David H. ;
Ruesch-Gerdes, Sabine ;
Gotuzzo, Eduardo ;
Rodrigues, Camilla ;
Alland, David ;
Perkins, Mark D. .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (11) :1005-1015
[5]   Minimum package for cross-border TB control and care in the WHO European region: a Wolfheze consensus statement [J].
Dara, Masoud ;
de Colombani, Pierpaolo ;
Petrova-Benedict, Roumyana ;
Centis, Rosella ;
Zellweger, Jean-Pierre ;
Sandgren, Andreas ;
Heldal, Einar ;
Sotgiu, Giovanni ;
Jansen, Niesje ;
Bahtijarevic, Rankica ;
Migliori, Giovanni Battista .
EUROPEAN RESPIRATORY JOURNAL, 2012, 40 (05) :1081-1090
[6]   Treatment outcomes for children with multidrug-resistant tuberculosis: a systematic review and meta-analysis [J].
Ettehad, Dena ;
Schaaf, H. Simon ;
Seddon, James A. ;
Cooke, Graham S. ;
Ford, Nathan .
LANCET INFECTIOUS DISEASES, 2012, 12 (06) :449-456
[7]  
European Centre for Disease Prevention and Control/WHO Regional Office for Europe, 2012, TUB SURV MON EUR 201
[8]   High prevalence of childhood multi-drug resistant tuberculosis in Johannesburg, South Africa: a cross sectional study [J].
Fairlie, Lee ;
Beylis, Natalie C. ;
Reubenson, Gary ;
Moore, David P. ;
Madhi, Shabir A. .
BMC INFECTIOUS DISEASES, 2011, 11
[9]   WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update [J].
Falzon, D. ;
Jaramillo, E. ;
Schuenemann, H. J. ;
Arentz, M. ;
Bauer, M. ;
Bayona, J. ;
Blanc, L. ;
Caminero, J. A. ;
Daley, C. L. ;
Duncombe, C. ;
Fitzpatrick, C. ;
Gebhard, A. ;
Getahun, H. ;
Henkens, M. ;
Holtz, T. H. ;
Keravec, J. ;
Keshavjee, S. ;
Khan, A. J. ;
Kulier, R. ;
Leimane, V. ;
Lienhardt, C. ;
Lu, C. ;
Mariandyshev, A. ;
Migliori, G. B. ;
Mirzayev, F. ;
Mitnick, C. D. ;
Nunn, P. ;
Nwagboniwe, G. ;
Oxlade, O. ;
Palmero, D. ;
Pavlinac, P. ;
Quelapio, M. I. ;
Raviglione, M. C. ;
Rich, M. L. ;
Royce, S. ;
Ruesch-Gerdes, S. ;
Salakaia, A. ;
Sarin, R. ;
Sculier, D. ;
Varaine, F. ;
Vitoria, M. ;
Walson, J. L. ;
Wares, F. ;
Weyer, K. ;
White, R. A. ;
Zignol, M. .
EUROPEAN RESPIRATORY JOURNAL, 2011, 38 (03) :516-528
[10]   Resistance to fluoroquinolones and second-Line injectable drugs: impact on multidrug-resistant TB outcomes [J].
Falzon, Dennis ;
Gandhi, Neel ;
Migliori, Giovanni B. ;
Sotgiu, Giovanni ;
Cox, Helen S. ;
Holtz, Timothy H. ;
Hollm-Delgado, Maria-Graciela ;
Keshavjee, Salmaan ;
DeRiemer, Kathryn ;
Centis, Rosella ;
D'Ambrosio, Lia ;
Lange, Christoph G. ;
Bauer, Melissa ;
Menzies, Dick .
EUROPEAN RESPIRATORY JOURNAL, 2013, 42 (01) :156-168